ALT-001 (Beijing Darwin Cell Biotechnology Co Ltd)
N/A
Report date: 2026/04/24 20:01:59
First In Class
Base Information
Drug NameALT-001 (Beijing Darwin Cell Biotechnology Co Ltd)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Darwin Cell Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Darwin Cell Biotechnology Co LtdDarwin Starting Point (Hubei) Biopharmaceutical Co LtdBeijing Tiantan Hospital, Capital Medical University
Inactive CompaniesN/A
Active Indications +[8]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A